Search

everythinglearnresearchcommunity

for

Search:↓

Viral reactivation is rare at the time of DRESS diagnosis in the U.S.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

VKHD and sarcoidosis may share a common cause.

Early recognition and treatment of VATS in transplant patients improve outcomes.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

A 19-month-old boy with a rare hair disorder showed mild improvement with treatment, but his family chose gentle hair care due to limited success.

γδ T cells are essential for wound healing after poxvirus infection.

Two boys developed a viral skin infection during chemotherapy, which resolved with improved immune function.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

A rare case of a transplant patient developing a skin condition linked to HPV-49.

The child has a scaly rash and fever, but tests show no infection.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

A woman lost her hair after taking acyclovir, but it grew back when she stopped the medication.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

The man's rash, hair loss, and vision issues were due to syphilis, not CMV.

COVID-19 can cause various skin symptoms, with different patterns seen in younger and older patients.

Hair gels may cause split ends in children.

COVID-19 and its vaccine can cause skin issues, but most are minor and resolve on their own.

COVID-19 infection or vaccination may trigger lichen planus.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

A man's baldness improved possibly due to a medication that blocks male hormones.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.